Vycor Medical (VYCO) EBITDA Margin (2010 - 2026)
Vycor Medical's (VYCO) quarterly EBITDA Margin came in at 1.64% in Q2 2026, down 867.0% year-over-year from 0.21% in Q2 2025, and down 83.6% quarter-over-quarter from 9.99% in Q1 2026.
Powered by 
Analysis
Vycor Medical (VYCO) EBITDA Margin (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported EBITDA Margin for 17 consecutive years, with 1.64% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin fell 867.0% year-over-year to 1.64% in Q2 2026; TTM through Jun 2026 was 2.67%, a 140.0% increase from a year earlier, with the FY2025 full-year figure at 1.82%, up 239.0% from the prior year.
- EBITDA Margin was 1.64% for Q2 2026 at Vycor Medical, down from 9.99% in the prior quarter.
- Over five years, EBITDA Margin peaked at 19.99% in Q2 2023 and troughed at 33.62% in Q4 2022.
- A 5-year average of 4.92% and a median of 2.88% in 2025 frame the typical range for EBITDA Margin.
- The widest YoY moves for EBITDA Margin: up 5308 bps in 2022, down 2746 bps in 2022.
- Over 5 years, EBITDA Margin stood at 33.62% in 2022, then soared by 38 bps to 20.78% in 2023, then surged by 120 bps to 4.25% in 2024, then plunged by 306 bps to 8.76% in 2025, then soared by 119 bps to 1.64% in 2026.
- The last three EBITDA Margin figures came in at 1.64% (Q2 2026), 9.99% (Q1 2026), and 8.76% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 19.15% |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | 1.64% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.64% |
| Mar 31, 2026 | 9.99% |
| Dec 31, 2025 | -8.76% |
| Sep 30, 2025 | 6.24% |
| Jun 30, 2025 | 10.30% |
| Mar 31, 2025 | -2.93% |
| Dec 31, 2024 | 4.25% |
| Sep 30, 2024 | -8.99% |
| Jun 30, 2024 | 3.98% |
| Mar 31, 2024 | -2.83% |
| Dec 31, 2023 | -20.78% |
| Sep 30, 2023 | -8.26% |
| Jun 30, 2023 | 19.99% |
| Mar 31, 2023 | 9.20% |
| Dec 31, 2022 | -33.62% |
| Sep 30, 2022 | -28.40% |
| Jun 30, 2022 | -22.68% |
| Mar 31, 2022 | -16.86% |
| Dec 31, 2021 | -59.99% |
| Sep 30, 2021 | -26.62% |